Pancreatic cancer research funding 'shameful'; Lung cancer rates shoot up for women over 60;

Cancer Research

> Research by RPI doctoral student Sevan Goenezen holds the promise of becoming a powerful new weapon in the fight against breast cancer. His complex computational research has led to a fast, inexpensive new method for using ultrasound and advanced algorithms to differentiate between benign and malignant tumors with a high degree of accuracy. Release

> Columnist highlights "shameful lack of research dollars" for pancreatic cancer. Article

> Lung cancer rates have more than doubled for women over 60 since the mid-1970s. Story

Genetics

> Researchers in two major international studies have discovered 17 new genetic variants linked with increased heart disease risk. The research more than doubles the known firm genetic links to coronary heart disease. More here

> Gene therapy that boosts the ability of brain cells to gobble up toxic proteins prevents development of Alzheimer's disease in mice that are predestined to develop it. Georgetown release

> Scientists have identified a single mutated gene that causes Hajdu-Cheney syndrome, a disorder of the bones causing progressive bone loss and osteoporosis. King's College release

Stem Cells

> Stem cell research in Australia is being stifled by red tape, says a research lab. Story

> Human cells derived from stem cells restore movement in rats with spinal cord injuries. Report

> Transplanting stem cells derived from umbilical cord blood cells and menstrual blood cells may offer future therapeutic benefit for those suffering from stroke, Alzheimer's disease and amyotrophic lateral sclerosis. Release

Suggested Articles

Removing the IRE1-alpha gene from beta cells in mouse models of Type 1 diabetes restored normal insulin production, scientists found.

Selectively targeting TGF-beta1 with Scholar Rock's SRK-181 overcame primary resistance to checkpoint inhibitor therapy in mice.

Enhertu produced a 55.6% objective response rate in HER2-positive non-small cell lung cancer patients in a phase 1 trial.